Source: Annual Congress 2006 - Evaluation of drugs for the treatment of lung diseases
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Santus, S. Centanni, A. Mantero, P. Carlucci, L. Bosotti, B. Boveri, M. Mondoni, M. Cazzola (Milan, Naples, Italy). Doppler echocardiographic assessment of the effects of inhaled LABAs on pulmonary artery pressure (PAP) in COPD. Eur Respir J 2006; 28: Suppl. 50, 2539

Member's Comments

No comment yet.

Related content which might interest you: Transthoracic echocardiography and pulmonary artery pressure assessment in patients with COPD exacerbation Source: Annual Congress 2011 - Functional lung and pulmonary arterial imaging Year: 2011 Noninvasive and invasive evaluation of pulmonary arterial pressure in highlanders Source: Eur Respir J 2007; 29: 352-356 Year: 2007 Doppler echocardiographic evaluation of pulmonary artery pressure in children with acute pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 239s Year: 2007 Estimating pulmonary artery pressures by echocardiography in patients with emphysema Source: Eur Respir J 2007; 30: 914-921 Year: 2007 Mean pulmonary artery diameter (MPAD) on CT scan versus pulmonary artery systolic pressure (PASP) on echocardiogram in interstitial lung disease (ILD) patients Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease Year: 2008 Accuracy of echocardiography to detect pulmonary hypertension in severe COPD Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009 Acquisition of echo-Doppler parameters of pulmonary hypertension in COPD Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Effects of continuous positive airway pressure (nCPAP) on pulmonary hemodynamics in COPD patients with overlap syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 568s Year: 2004 Long-term effects of bosentan on the heart and pulmonary hemodynamics in pulmonary arterial hypertension, a comparison study with epoprostenol Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005 Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Pulmonary artery pressure (PAP) reduction by systemic and inhaled nitroglycerin (NTG) in an isolated rabbit lung model of pulmonary hypertension (PH) Source: Eur Respir J 2003; 22: Suppl. 45, 270s Year: 2003 Pulmonary artery distensibility in pulmonary arterial hypertension: an MRI pilot study Source: Eur Respir J 2007; 29: 476-481 Year: 2007 Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD Source: Eur Respir J 2001; 17: 350-355 Year: 2001 Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension Year: 2005 Haemodynamic responses to exercise in patients with COPD Source: Eur Respir J 2013; 41: 1031-1041 Year: 2013 Noninvasive evaluation of pulmonary artery pressure during exercise: the importance of right atrial hypertension Source: Eur Respir J, 55 (2) 1901617; 10.1183/13993003.01617-2019 Year: 2020 Effects of salmeterol on heart rate variability in patients with bronchial asthma and coronary artery disease Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma Year: 2008 Diagnosis of left ventricular diastolic dysfunction using echocardiography in COPD patients with pulmonary arterial hypertension Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Prediction (indirect determination) of pulmonary artery pressure by transcutaneous echo-Doppler Source: Eur Respir J 2005; 26: Suppl. 49, 351s Year: 2005 Selection of the optimal nebulizer for further clinical development of inhaled nebulized nitrite (AIR001) in pulmonary arterial hypertension patients Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012